aripiprazole has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JY; Kim, MY; Yoo, S | 1 |
| Aguiar, DC; Almeida-Santos, AF; Duarte, IDG; Ferreira, RCM; Moreira, FA; Romero, TRL | 1 |
2 other study(ies) available for aripiprazole and dinoprostone
| Article | Year |
|---|---|
Syk and Src-targeted anti-inflammatory activity of aripiprazole, an atypical antipsychotic.
Topics: Animals; Anti-Inflammatory Agents; Aripiprazole; Cell Survival; Dinoprostone; Dopamine Agonists; Gene Expression Regulation; HEK293 Cells; Humans; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Peptidoglycan; RAW 264.7 Cells; src-Family Kinases; Syk Kinase | 2018 |
Role of Endocannabinoid System in the Peripheral Antinociceptive Action of Aripiprazole.
Topics: Analgesics; Animals; Aripiprazole; Cannabinoid Receptor Agonists; Dinoprostone; Disease Models, Animal; Endocannabinoids; Hyperalgesia; Male; Mice; Nociceptive Pain; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2019 |